#USA #Kansas City #ETF #American Century #LVOL

American Century Investments to Close Low Volatility ETF

On March 12, 2025, American Century Investments announced that it will be liquidating its American Century Low Volatility ETF (LVOL). This decision comes as part of a strategic realignment of their exchange-traded funds (ETFs). The trading for LVOL on the NYSE Arca, Inc. will conclude on April 22, 2025, marking the end of the ETF's operations in the market.

Following this date, shareholders will no longer be able to trade their shares on the exchange. The liquidation process is set to begin around April 29, 2025, when the fund's remaining assets will be distributed to investors who have yet to sell or redeem their shares. It's important to note that prior to this liquidation, the fund may temporarily adjust its investment strategies, which diverges from its stated objectives, to facilitate the final distribution.

As of February 12, 2025, American Century Investments boasts assets under management totaling around $59.7 billion, reflecting the firm's solid standing in the investment management industry. This closure decision indicates a calculated move by the company to optimize its ETF offerings and enhance operational efficiency.

About American Century Investments

Founded in 1958, American Century Investments is a prominent global asset management firm dedicated to providing outstanding investment results and fostering long-term relationships with its clients. The firm operates from multiple locations, including Kansas City, New York, Los Angeles, and several international offices in cities such as London, Frankfurt, Hong Kong, and Sydney. The company prides itself on its commitment to generate meaningful returns for clients while also supporting innovative medical research through its philanthropic efforts.

With a workforce of over 1,400 employees, American Century serves a diverse clientele that includes financial professionals, institutions, corporations, and individual investors. Notably, more than 40% of the company's dividends are redirected to the Stowers Institute for Medical Research — a nonprofit organization dedicated to basic biomedical research. Since the year 2000, the Institute has benefitted from dividends exceeding $2 billion, highlighting American Century's commitment to social responsibility.

As many investors and analysts monitor these developments, it remains clear that American Century Investments is making strategic decisions that align with its broader mission of delivering value to shareholders while supporting crucial medical research initiatives. For those interested in staying updated with American Century’s endeavors and investment strategies, further information can be accessed through their official website.

American Century Investments continues to adapt to the dynamic landscape of the investment market, and the closure of LVOL marks just one of the many adjustments the firm may undertake as it moves forward in 2025. Stakeholders are encouraged to observe how these changes might influence the firm's overall growth trajectory and investment framework in the coming years.